When 3rd Stone Design, a product design, strategy, and development consultancy, licensed the DoseRight Syringe Clip out of the Rice University Beyond Traditional Borders (BTB) program, the Clinton Health Access Initiative (CHAI) had placed a preliminary order for 200,000 units. The DoseRight product was a simple plastic clip, inserted into the top portion of a standard oral syringe to facilitate the accurate pediatric dosing of liquid ARV medications in countries with widespread HIV/AIDs.
The functional prototype developed by the student team was shown to work effectively. The problem was that it could not be manufactured in high volumes at an affordable price. This mini-case study explores how 3rd Stone Design modified the product design to support high-volume production and fulfill the CHAI order.
This story is part of the Global Health Innovation Insight Series developed at Stanford University to shed light on the challenges that global health innovators face as they seek to develop and implement new products and services that address needs in resource-constrained settings.
Acknowledgements: We would like to thank Robert Miros of 3rd Stone Design for his participation. This research was supported by the National Institutes of Health grant 1 RC4 TW008781-01.